[Search for antibodies against human immunodeficiency virus type 2 (HIV-2) in a sample of parenteral drug addicts (IVDA)] NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Search for antibodies against human immunodeficiency virus type 2 (HIV-2) in a sample of parenteral drug addicts (IVDA)]

Enferm Infecc Microbiol Clin. 1990 Jan;8(1):48-51. Unique Identifier : AIDSLINE MED/91255530
Ortiz de Lejarazu R; Eiros JM; Perlado del Campo E; Palenzuela MS; Reguera JI; Rodriguez-Torres A; Facultad de Medicina y Hospital Clinico, Valladolid.

Abstract: We have retrospectively investigated the antibodies against type 2 human immunodeficiency virus (Ac HIV-2) in sera from parenteral drug abusers (PDA) who had been previously investigated for HIV-1 and who fulfilled established criteria (trips, sexual contacts, etc.). Enzyme immunoassay (EIA) was positive in 7 individuals who were also carriers of HIV-1. When HIV-2 was confirmed with Western blot, in only one case a tenuous band against glycoprotein 105 (gp 105) and the remaining ones from the core was found.
Keywords: Adult Blotting, Western English Abstract Human HIV Antibodies/*ANALYSIS HIV Infections/DIAGNOSIS/ETIOLOGY/*MICROBIOLOGY HIV-1/IMMUNOLOGY/ISOLATION & PURIF HIV-2/IMMUNOLOGY/*ISOLATION & PURIF Immunoenzyme Techniques Male Prisoners Retrospective Studies Substance Abuse, Intravenous/*COMPLICATIONS JOURNAL ARTICLEKWDadultblotting,westernenglishabstracthumanhivantibodies/KWDanalysishivinfections/diagnosis/etiology/KWDmicrobiologyhiv-1/immunology/isolation&purifhiv-2/immunology/KWDisolation&purifimmunoenzymetechniquesmaleprisonersretrospectivestudiessubstanceabuse,intravenous/KWDcomplicationsjournalarticle
910930
M9190672

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .